Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Fares

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Neurotoxicology|January 1, 1989
Neural and behavioral alterations after early exposure to phenobarbitalJ Yanai, F Fares, M Gavish, et al.
Journal of Medical Virology|March 24, 1999
High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's diseaseE Drouet, P Brousset, F Fares, et al.
Ecancermedicalscience|January 11, 2020
Complete metastasectomy in renal cell carcinoma: a propensity-score matched by the International Metastatic RCC Database Consortium prognostic modelAline F Fares, Daniel V Araujo, Vinicius Calsavara, et al.
Cancer Medicine|April 9, 2026
Smoking After a Cancer Diagnosis in Brazil: Divergent Perceptions and Awareness of Tobacco-Related Harms Among Patients and CaregiversV S Lemos, T E Colombo, M Saleh, et al.
Esophagus : Official Journal of the Japan Esophageal Society|January 11, 2023
Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinomaUlf Zeuge, Aline F Fares, Joelle Soriano, et al.
JTO Clinical and Research Reports|October 4, 2022
Assessing Oncologists' Attitudes Concerning Comprehensive Genomic Profiling in Stage IV Lung Adenocarcinoma in BrazilAline F Fares, Pedro H Martinez, Pedro H Farina, et al.
JCO Global Oncology|November 21, 2024
Low-Dose Anti-PD(L)1 for the Treatment of Solid MalignanciesIza Andrade de A Souza, Beatriz de M Dobbert, Barbara G Sao Jose, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2020
ALK-rearranged lung adenocarcinoma transformation into high-grade large cell neuroendocrine carcinoma: Clinical and molecular description of two casesAline F Fares, Benjamin H Lok, Tong Zhang, et al.
JTO Clinical and Research Reports|March 4, 2024
Health Services Access Inequalities in Brazil Result in Poorer Outcomes for Stage III NSCLC-RELANCE/LACOG 0118Vladmir C Cordeiro de Lima, Ana Gelatti, José F P Moura, et al.
JCO Global Oncology|June 24, 2026
Treatment of ALK+ Non-Small Cell Lung Cancer in the Brazilian Public and Private Health Care Systems: A Tale of Inequalities (LACOG/GBOT 1918)Eldsamira Mascarenhas, Ana C Z Gelatti, Tatiane Montella, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Neurotoxicology|January 1, 1989
Neural and behavioral alterations after early exposure to phenobarbitalJ Yanai, F Fares, M Gavish, et al.
Journal of Medical Virology|March 24, 1999
High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's diseaseE Drouet, P Brousset, F Fares, et al.
Ecancermedicalscience|January 11, 2020
Complete metastasectomy in renal cell carcinoma: a propensity-score matched by the International Metastatic RCC Database Consortium prognostic modelAline F Fares, Daniel V Araujo, Vinicius Calsavara, et al.
Cancer Medicine|April 9, 2026
Smoking After a Cancer Diagnosis in Brazil: Divergent Perceptions and Awareness of Tobacco-Related Harms Among Patients and CaregiversV S Lemos, T E Colombo, M Saleh, et al.
Esophagus : Official Journal of the Japan Esophageal Society|January 11, 2023
Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinomaUlf Zeuge, Aline F Fares, Joelle Soriano, et al.
JTO Clinical and Research Reports|October 4, 2022
Assessing Oncologists' Attitudes Concerning Comprehensive Genomic Profiling in Stage IV Lung Adenocarcinoma in BrazilAline F Fares, Pedro H Martinez, Pedro H Farina, et al.
JCO Global Oncology|November 21, 2024
Low-Dose Anti-PD(L)1 for the Treatment of Solid MalignanciesIza Andrade de A Souza, Beatriz de M Dobbert, Barbara G Sao Jose, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2020
ALK-rearranged lung adenocarcinoma transformation into high-grade large cell neuroendocrine carcinoma: Clinical and molecular description of two casesAline F Fares, Benjamin H Lok, Tong Zhang, et al.
JTO Clinical and Research Reports|March 4, 2024
Health Services Access Inequalities in Brazil Result in Poorer Outcomes for Stage III NSCLC-RELANCE/LACOG 0118Vladmir C Cordeiro de Lima, Ana Gelatti, José F P Moura, et al.
JCO Global Oncology|June 24, 2026
Treatment of ALK+ Non-Small Cell Lung Cancer in the Brazilian Public and Private Health Care Systems: A Tale of Inequalities (LACOG/GBOT 1918)Eldsamira Mascarenhas, Ana C Z Gelatti, Tatiane Montella, et al.
Pageof 5